Search Count: 16
 |
Factor Xia In Complex With The Inhibitor Methyl [(2R,7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-2-(Trifluoromethyl)-2,3,4,5,6,7-Hexahydro-1H-8,11-Epimino-1,9-Benzodiazacyclotridecin-14-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2020-01-29 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QLS, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl (2R,7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-14-[(Methoxycarbonyl)Amino]-2,3,4,5,6,7-Hexahydro-1H-8,11-Epimino-1,9-Benzodiazacyclotridecine-2-Carboxylate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2020-01-29 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QLM, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Ethyl (2R,7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-14-[(Methoxycarbonyl)Amino]-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecine-2-Carboxylate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2020-01-29 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QLD, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Ethyl (2R,7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-15-[(Methoxycarbonyl)Amino]-2,3,4,5,6,7-Hexahydro-1H-12,8-(Metheno)-1,9-Benzodiazacyclotetradecine-2-Carboxylate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2020-01-29 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QLJ, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(3R,7S)-7-{[5-Amino-1-(3-Chloro-2-Fluorophenyl)-1H-Pyrazole-4-Carbonyl]Amino}-3-Methyl-2-Oxo-2,3,4,5,6,7-Hexahydro-1H-12,8-(Metheno)-1,9-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2019-12-25 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QEY, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(3R,7S)-7-{[1-(3-Chloro-2-Fluorophenyl)-5-Methyl-1H-Imidazole-4-Carbonyl]Amino}-3-Methyl-2-Oxo-2,3,4,5,6,7-Hexahydro-1H-12,8-(Metheno)-1,9-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2019-12-25 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: QEV, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-2-Oxo-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecin-14-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2017-07-12 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: 9EY, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(4S,8S)-8-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-4-Methyl-2-Oxo-1,3,4,5,6,7,8,10-Octahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2017-07-12 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: 9FD, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(4R,5E,8S)-8-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-4-Methyl-2-Oxo-1,3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2017-07-12 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: 9FA, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(3R,7S)-7-({(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}Amino)-3-Ethyl-2-Oxo-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecin-14-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2017-07-12 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: 9F7, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl [(4R,5E,8S)-11-Chloro-8-[(2,6-Difluoro-4-Methylbenzene-1-Carbonyl)Amino]-4-Methyl-2-Oxo-1,3,4,7,8,10-Hexahydro-2H-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2017-07-12 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: 9F1, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor ((15S)-18-Chloro- 15-(((2E)-3-(5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl)-2- Propenoyl)Amino)-17,19-Diazatricyclo[14.2.1.0~2,7~]Nonadeca-1(18),2,4,6,16(19)-Pentaen-5-Yl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2017-03-01 Classification: hydrolase/hydrolase inhibitor Ligands: 7DL, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl ((12E,15S)-15-(((2E)-3-(5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl)-2-Propenoyl)Amino)-9-Oxo-8,17,19-Triazatricyclo[14.2.1.0~2,7~]Nonadeca-1(18),2,4,6,12,16(19)-Hexaen-5-Yl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2017-03-01 Classification: hydrolase/hydrolase inhibitor Ligands: 7DS, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor Methyl ((15S)-15-(((2E)-3-(5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl)-2-Propenoyl)Amino)-9-Oxo-8,17,19-Triazatricyclo[14.2.1.0~2,7~]Nonadeca-1(18),2,4,6,16(19)-Pentaen-5-Yl)Carbamate
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2017-03-01 Classification: hydrolase/hydrolase inhibitor Ligands: 7DK, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor 4-[(N-{(2E)-3-[5-Chloro-2-(1H-Tetrazol-1-Yl)Phenyl]Prop-2-Enoyl}-L-Phenylalanyl)Amino]Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2015-12-09 Classification: Hydrolase/Hydrolase Inhibitor Ligands: 5JM, SO4, EDO |
 |
Factor Xia In Complex With The Inhibitor N-[(1S)-1-Benzyl-2-[2-[5-Chloro-2-(Tetrazol-1-Yl)Phenyl]Ethylamino]-2-Oxo-Ethyl]-4-Hydroxy-2-Oxo-1H-Quinoline-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2015-12-09 Classification: Hydrolase/Hydrolase Inhibitor Ligands: 7P0, SO4, EDO |